Oregon hospitals have reported a modest decline in health care-associated infections (HAIs) among patients in 2023, according ...

Antimicrobial resistance (AMR) data from 2012 through 2022 shows that the number of drug-resistant infections in hospitals has largely gone down, though it is still significant, according to a study ...

With the rising prevalence of methicillin-resistant Staphylococcus ( S .) aureus (MRSA), a multi drug resistant strain, ...

The study, conducted by researchers with the Centers for Disease Control and Prevention (CDC), found that six bacterial ...

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

With the rising prevalence of methicillin-resistant Staphylococcus (S.) aureus (MRSA), a multi drug resistant strain, treatment has become a ...

A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants of the dangerous pathogenic bacteria Staphylococcus aureus.

Bloodstream infections require rapid identification to prevent ... Methicillin-Sensitive Staphylococcus aureus (MSSA), Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli (E. coli), ...

Background: Sepsis remains a leading cause of mortality in intensive care units (ICUs), with methicillin-resistant Staphylococcus aureus (MRSA) infections presenting significant treatment challenges.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of serious nosocomial infections, and recurrent MRSA infections primarily result from the survival of persister cells after ...